#rheumtwitter #sarcoid #rheumatology #Deucravacitinib
---
RT @SteZhao
🚨TYK2 inhibition is associated with reduced risk of sarcoidosis.

Suggesting that #TYK2 inhibitors eg #deucravacitinib - trialed for psoriasis/PsA - may be worth testing for treatment of #sarcoidosis - chronic condition for which few drugs are approved.
https://ard.bmj.com/content/82/3/445
https://twitter.com/SteZhao/status/1639640115092893696